Skip to content
Review

Curcumin nanoformulations for modulating neuroinflammation and oxidative stress in Alzheimer’s disease: blood–brain barrier transport, formulation strategies and therapeutic applications

Sep 2026 · InflammoPharmacology · Vol 34, pp. 6519 - 6548 · 1 citation · 127 references
Medicine

TL;DR

Collectively, nanocarrier-mediated curcumin delivery represents a promising pharmaceutical strategy to improve brain-specific bioavailability and enable effective multitarget therapeutic intervention in AD.

View source

Similar papers

Review Open access Sep 2026

Herbal nanoparticles in the treatment of neurodegeneration: from molecular mechanisms to therapeutic translation

This review critically summarizes recent advances in herbal nanoformulations, emphasizing disease-specific molecular targets, BBB-targeting strategies, comparative nanocarrier systems, pharmacokinetic optimization, intracellular trafficking, and translational challenges.

D. Mittal, Pavitra Solanki, G. K. Jain et al. · 1 citation
Review Oct 2026

Hyaluronic acid-based CeO₂ nanozymes for brain-targeted Parkinson's disease therapy: Biointerface design, multifunctional neuroprotective regulation and future perspectives: A review.

This review systematically summarizes recent advances in HA-CeO₂ nanozyme platforms for PD therapy, with key findings indicating multifaceted neuroprotection through modulation of oxidative stress, mitochondrial dysfunction, neuroinflammation, α-synuclein pathology, and ferroptosis.

Qu-Cheng Huang, Yun-Wei Sun, Y. Duan et al. · 0 citations
Review Sep 2026

Nose-to-Brain Delivery of Polyherbal Nanoformulations in Neurodegenerative Disorders: Translational Strategies and Challenges

The current knowledge on polyherbal synergy, nanocarrier-based targeting methods, and nose-to-brain delivery strategies to treat neurodegenerative disorders are summarized, highlighting their potential therapeutic applications, underlying mechanisms, translational issues, regulatory factors, and emerging trends such as...

Mahalakshmi Seelam, Varalakshmi Sagili · 0 citations
Review Open access Sep 2026

The Role of Curcumin in Neurogenesis and Neuroprotection in Alzheimer’s disease: From Molecular Mechanisms to Clinical Evidence

This review discusses multi-target neuroprotective mechanisms of curcumin, critically reviews the preclinical success and human clinical trial outcomes, and highlights advanced nano formulations (solid lipid nanoparticles, colloidal sub-micron dispersions, polymeric nanoparticles, multi-walled carbon nanotubes and exos...

V. S, Sarupruthiya M, Jeevitha D et al. · 0 citations
Review Open access Sep 2026

Efficacy of Curcumin in Neurodegenerative Diseases: From Pharmacokinetic Barriers to Advanced Delivery Systems

Background and Objectives: The main neurodegenerative diseases (NDs)—Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS)—represent a growing global health burden with no available disease-modifying therapies. Curcumin, a polyphenol from Curcuma longa, is...

Alejandra Castelló-Guillen, Marta Garrido-Reig, Jordi Caplliure-Llopis et al. · 0 citations
Review Sep 2026

Bioinspired Nanomaterials for Parkinson's Disease: Engineering Membrane Interfaces to Overcome the Blood-Brain Barrier and Enable Neuron-Targeted Delivery.

Parkinson's disease (PD) is a progressive neurodegenerative disorder marked by the selective loss of dopaminergic neurons in the substantia nigra, which gives rise to characteristic motor and non-motor behavioral impairments. Disease-modifying therapies remain elusive, largely due to the restrictive nature of the blood...

Qu-Cheng Huang, Yuan-Yuan Zuo, Yi-Ning Xie et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.